In 2023, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved more than 6,700 chemical drug evaluation applications that were subjected to technical reviews. The approvals included 1,448 Investigational New Drug (IND) applications, more than 900 therapeutic effect consistency assessment requests, and 186 New Drug Applications (NDA). The number of Abbreviated New Drug Applications (ANDA) also exceeded 1,800. An ANDA application is a drug approval application submitted to the regulatory body for the general approval and sale of a generic drug product.
Number of approved registration applications for chemical drugs subjected to technical reviews in China in 2023, by type of application
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (February 4, 2024). Number of approved registration applications for chemical drugs subjected to technical reviews in China in 2023, by type of application [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319958/china-number-of-chemical-drug-evaluation-applications-approved-by-type/
National Medical Products Administration. "Number of approved registration applications for chemical drugs subjected to technical reviews in China in 2023, by type of application." Chart. February 4, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319958/china-number-of-chemical-drug-evaluation-applications-approved-by-type/
National Medical Products Administration. (2024). Number of approved registration applications for chemical drugs subjected to technical reviews in China in 2023, by type of application. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319958/china-number-of-chemical-drug-evaluation-applications-approved-by-type/
National Medical Products Administration. "Number of Approved Registration Applications for Chemical Drugs Subjected to Technical Reviews in China in 2023, by Type of Application." Statista, Statista Inc., 4 Feb 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319958/china-number-of-chemical-drug-evaluation-applications-approved-by-type/
National Medical Products Administration, Number of approved registration applications for chemical drugs subjected to technical reviews in China in 2023, by type of application Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319958/china-number-of-chemical-drug-evaluation-applications-approved-by-type/ (last visited November 10, 2024)
Number of approved registration applications for chemical drugs subjected to technical reviews in China in 2023, by type of application [Graph], National Medical Products Administration, February 4, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1319958/china-number-of-chemical-drug-evaluation-applications-approved-by-type/
